loader image
Sunday, December 21, 2025
87.1 F
McAllen
- Advertisement -

Exploring Radiation-Induced Toxicities from a Nursing Perspective

Translate to Spanish or other 102 languages!

Radiation therapy uses high doses of radiation to destroy cancer cells. Image for illustration purposes
Radiation therapy uses high doses of radiation to destroy cancer cells. Image for illustration purposes

Mega Doctor News

- Advertisement -

By Rutgers Cancer Institute of New Jersey

Newswise — New Brunswick, N.J.  – Radiation therapy uses high doses of radiation to destroy cancer cells. Unfortunately, receiving this type of treatment for cancers in the pelvic region can cause painful inflammation of the rectum, called radiation proctitis (RP). Dorothy N. Pierce, DNP, NP-C, CRN, CBCN, a nurse practitioner in the Department of Radiation Oncology at Rutgers Cancer Institute of New Jersey, highlights the role of advanced practice nurses (APNs) in providing supportive care for patients experiencing RP, which will be presented as a poster at the upcoming 2022 American Association of Nurse Practitioner (AANP) National Conference in Orlando, Florida from June 21 to June 26.

Why is this topic important to explore? 

- Advertisement -

Most patients diagnosed with cancer will receive radiation therapy sometime during their cancer journey. Regrettably, an unusual number of patients who receive pelvic radiation therapy for various pelvic malignancies suffer from significant radiation-induced toxicities that impact the patient’s quality of life (QOL). In addition, these survivors exhibit a range of psychological, physical, and supportive care needs that exist many years after diagnosis and completion of active treatment. Although new devices and emerging radiation therapy technologies exist, radiation side effects can occur months to years after treatment ends. Therefore, radiation oncology (RO) clinicians can best prepare survivors with education about long-term and late occurring effects such as RP. Likewise, non-oncology clinicians should be mindful of RP when assessing pelvic RT patients who present with diarrhea and bleeding.

What role do nurses play in providing support for patients suffering from RP?

Radiation oncology nurses play a crucial role in assessing contributing factors and providing effective symptoms management, information, and counseling about radiotherapy side effects to patients and their caregivers. Primarily patient-related risk factors may include genomic, previous abdominal surgery, tumor size, and inflammatory bowel disease. In addition, RO nurses are well situated to offer detailed education information to patients who received radiation therapy to the pelvic region.

What are the implications of your findings? 

- Advertisement -

Many patients diagnosed with cancer face numerous psychosocial issues at diagnosis, pre-radiation, during, and post-treatment. The multidisciplinary team approach to cancer care is essential. The RO APNs have unique responsibilities such as disease-specific patient assessments, patient education, site-specific side effects management, and medication management, making active and post-treatment follow-up care essential. As radiotherapy continues to make technological advances and the opportunity for curative intent suggests that the role of RO nurses will become even more critical. Thus, advancing knowledge and research is paramount to site-specific side effects in this area to stay current.  

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×